CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-20 | EHRLICH JASON See Remarks | Sale | −2,090 | $61.71 | $129K | 31,284 |
| 2020-05-20 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | −6,950 | 403,075 | ||
| 2020-04-20 | EHRLICH JASON See Remarks | Option exercise | +6,950 | $10.29 | $72K | 38,234 |
| 2020-04-20 | EHRLICH JASON See Remarks | Sale | −1,639 | $52.44 | $86K | 36,595 |
| 2020-04-20 | EHRLICH JASON See Remarks | Sale | −551 | $53.34 | $29K | 36,044 |
| 2020-04-20 | EHRLICH JASON See Remarks | Sale | −2,836 | $54.50 | $155K | 33,208 |
| 2020-04-20 | EHRLICH JASON See Remarks | Sale | −1,924 | $55.20 | $106K | 31,284 |
| 2020-04-20 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | −6,950 | 410,025 | ||
| 2020-04-09 | EHRLICH JASON See Remarks | Option exercise | +15,000 | 37,542 | ||
| 2020-04-09 | EHRLICH JASON See Remarks | Shares withheld for taxes | −4,058 | $50.67 | $206K | 33,484 |
| 2020-04-09 | EHRLICH JASON See Remarks | Sale | −938 | $47.54 | $45K | 32,546 |
| 2020-04-09 | EHRLICH JASON See Remarks | Sale | −345 | $48.70 | $17K | 32,201 |
| 2020-04-09 | EHRLICH JASON See Remarks | Sale | −917 | $49.55 | $45K | 31,284 |
| 2020-04-09 | EHRLICH JASON See Remarks | Option exercise · Restricted Stock Units | −15,000 | 15,000 | ||
| 2020-04-02 | Bancroft Charles A Director | Grant or award · Stock Option (Right to Buy) | +14,293 | 14,293 | ||
| 2020-04-02 | Liang Hong SVP, Discovery Medicine | Sale | −4,000 | $42.34 | $169K | 130,166 |
| 2020-03-26 | Liang Hong SVP, Discovery Medicine | Sale | −2,545 | $47.28 | $120K | 135,621 |
| 2020-03-26 | Liang Hong SVP, Discovery Medicine | Sale | −1,103 | $48.53 | $54K | 134,518 |
| 2020-03-26 | Liang Hong SVP, Discovery Medicine | Sale | −352 | $49.00 | $17K | 134,166 |
| 2020-03-20 | Levy Richard S Director | Purchase | +250 | $43.37 | $11K | 250 |
Page 31 of 37 · 722 trades